Cytospire Therapeutics
Cytospire Therapeutics
cytospire.com

Locations

London, UK

industry

Biotechnology

Size

11 - 50 employees

Stage

Seed

founded in

2023

Cytospire Therapeutics is a London-based biotechnology company specializing in the development of next-generation cancer immunotherapies. The company officially emerged from stealth in early 2024 and is led by CEO Natalie Mount, who previously headed Takeda-acquired startups Adaptate Biotherapeutics and GammaDelta Therapeutics.

Something looks off?
Open jobs at Cytospire Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.